Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Gene Silencing Market Size Changed, over the years?
The value of the gene silencing market has experienced swift expansion in recent times, with predictions that it will increase from $5.97 billion in 2024 to $6.75 billion in 2025. This equates to a compound annual growth rate (CAGR) of 13.0%. This remarkable growth in the stated time frame is due to various factors including advances in genetic therapy research, initial successes in RNA interference, escalating instances of genetic ailments, heightened investment in biotechnology, along with expanded biopharmaceutical production capabilities.
How Much Will the Gene Silencing Market Be Worth in 2029?
The gene silencing industry is projected to experience swift expansion in the coming years, with expectations that it will reach a market value of $10.95 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.9%. This projected growth within the forecast period can be credited to a range of influences including a broadening application base in the treatment of rare diseases, advancements in technology pertaining to delivery systems, growing demand for personalized medicinal treatments, governmental support initiatives, and continual partnerships between pharmaceutical and biotech companies. The forecast period sees trends such as the evolution of targeted gene therapies, the increasing adoption of CRISPR-based silencing methods, an amplified focus on rare and orphan diseases, the advent of nanoparticle delivery technologies, and the diversification into gene silencing applications within the agricultural sector.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp
Which is the Largest Company in the Gene Silencing Market?
Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.
What Are the Main Market Drivers in the Gene Silencing Industry?
The escalation of genetic conditions is anticipated to spur the expansion of the gene silencing market in the future. Genetic conditions are health-related issues caused by changes in a person’s DNA. Due to improvements in diagnostic methods, increased consciousness, and wider accessibility to genetic testing, these conditions are being identified more frequently. The incidence of genetic conditions is rising due to the advanced age of parents, which increases the risk of passing genetic changes to their children. Gene silencing offers a potential remedy for genetic disorders by selectively turning off the genes that cause illness or defects. A case in point is in August 2023, Down Syndrome UK, a charity based in the UK, reported that approximately 40,000 people in the UK are affected by Down syndrome, with an estimated 1 in every 800 babies born with this condition. Hence, the increasing incidence of genetic diseases is fueling the growth of the gene silencing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp
How Is the Gene Silencing Market Segments Structured?
The gene silencing market covered in this report is segmented –
1) By Type: Transcriptional, Post-Transcriptional, Meiotic
2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings
3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications
4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users
Subsegments:
1) By Transcriptional: DNA Methylation, Histone Modification
2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing
3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing
What Strategic Trends Are Transforming the Gene Silencing Market?
Leading firms in the gene silencing market are concentrating on the creation of innovative technologies such as small interfering RNA (siRNA) to increase accuracy and effectiveness in gene therapy. Small interfering RNA (siRNA) is a form of RNA molecule that is pivotal in the RNA interference (RNAi) pathway. It attaches to specific messenger RNA (mRNA), promotes its destruction, and stops the formation of proteins that cause disease. For instance, in October 2024, Judo Bio Inc., a biotech firm based in the US, introduced siRNA- a revolutionary drug that uses small interfering RNA (siRNA) to suppress genes. Key characteristics consist of unique delivery systems like lipid nanoparticles or bound ligands that guarantee effective absorption by particular cells or tissues and AI-powered platforms that expedite the finding of feasible gene targets.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report
Which Global Regions Offer the Highest Growth in the Gene Silencing Market?
North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp
This Report Delivers Insight On:
1. How big is the gene silencing market, and how is it changing globally?
2. Who are the major companies in the gene silencing market, and how are they performing?
3. What are the key opportunities and risks in the gene silencing market right now?
4. Which products or customer segments are growing the most in the gene silencing market?
5. What factors are helping or slowing down the growth of the gene silencing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model